The AlloStim™ treatment being investigated in this trial was developed by scientists at Hadassah-University Medical Center in Jerusalem.  The sponsor and owner of the investigational drug is Immunovative Therapies, Ltd., a small Israeli biopharmaceutical company.  www.immunovative.co.il